Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (331-340 of 451) with videos related to

Pageof 46
Sort By:
Neuropathology and Applied Neurobiology|December 18, 2020
Accurate calling of KIAA1549-BRAF fusions from DNA of human brain tumours using methylation array-based copy number and gene panel sequencing dataDamian Stichel, Daniel Schrimpf, Philipp Sievers, et al.
Journal of Personalized Medicine|December 23, 2020
Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated <i>ROS1/NTRK</i>-Fusion Positive Pediatric High-Grade GliomaLisa Mayr, Armin S Guntner, Sibylle Madlener, et al.
Molecular Cancer Research : MCR|January 14, 2021
Identification and Characterization of Cancer Cells That Initiate Metastases to the Brain and Other OrgansAnna S Berghoff, Yunxiang Liao, Matthia A Karreman, et al.
Neuro-Oncology|November 29, 2020
The genetic landscape of choroid plexus tumors in children and adultsChristian Thomas, Patrick Soschinski, Melissa Zwaig, et al.
Acta Neuropathologica Communications|June 1, 2022
The dural angioleiomyoma harbors frequent GJA4 mutation and a distinct DNA methylation profileArnault Tauziède-Espariat, Thibaut Pierre, Michel Wassef, et al.
Neuro-Oncology|June 24, 2024
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?Martin J van den Bent, Pim J French, Daniel Brat, et al.
Neuro-Oncology|September 23, 2021
Impact of the methylation classifier and ancillary methods on CNS tumor diagnosticsZhichao Wu, Zied Abdullaev, Drew Pratt, et al.
Acta Neuropathologica|July 18, 2024
Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterationsPhilipp Sievers, Franck Bielle, Kirsten Göbel, et al.
Acta Neuropathologica|September 18, 2021
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma typesPhilipp Sievers, Damian Stichel, Martin Sill, et al.
Nature|September 20, 2019
Glutamatergic synaptic input to glioma cells drives brain tumour progressionVarun Venkataramani, Dimitar Ivanov Tanev, Christopher Strahle, et al.
Pageof 46

Showing results (331-340 of 451) with videos related to

Sort By:
Pageof 46
Neuropathology and Applied Neurobiology|December 18, 2020
Accurate calling of KIAA1549-BRAF fusions from DNA of human brain tumours using methylation array-based copy number and gene panel sequencing dataDamian Stichel, Daniel Schrimpf, Philipp Sievers, et al.
Journal of Personalized Medicine|December 23, 2020
Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated <i>ROS1/NTRK</i>-Fusion Positive Pediatric High-Grade GliomaLisa Mayr, Armin S Guntner, Sibylle Madlener, et al.
Molecular Cancer Research : MCR|January 14, 2021
Identification and Characterization of Cancer Cells That Initiate Metastases to the Brain and Other OrgansAnna S Berghoff, Yunxiang Liao, Matthia A Karreman, et al.
Neuro-Oncology|November 29, 2020
The genetic landscape of choroid plexus tumors in children and adultsChristian Thomas, Patrick Soschinski, Melissa Zwaig, et al.
Acta Neuropathologica Communications|June 1, 2022
The dural angioleiomyoma harbors frequent GJA4 mutation and a distinct DNA methylation profileArnault Tauziède-Espariat, Thibaut Pierre, Michel Wassef, et al.
Neuro-Oncology|June 24, 2024
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?Martin J van den Bent, Pim J French, Daniel Brat, et al.
Neuro-Oncology|September 23, 2021
Impact of the methylation classifier and ancillary methods on CNS tumor diagnosticsZhichao Wu, Zied Abdullaev, Drew Pratt, et al.
Acta Neuropathologica|July 18, 2024
Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterationsPhilipp Sievers, Franck Bielle, Kirsten Göbel, et al.
Acta Neuropathologica|September 18, 2021
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma typesPhilipp Sievers, Damian Stichel, Martin Sill, et al.
Nature|September 20, 2019
Glutamatergic synaptic input to glioma cells drives brain tumour progressionVarun Venkataramani, Dimitar Ivanov Tanev, Christopher Strahle, et al.
Pageof 46